These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7979976)

  • 1. Vaccinia virus expression of the VP7 protein of South African bluetongue virus serotype 4 and its use as an antigen in a capture ELISA.
    Cloete M; du Plessis DH; van Dijk AA; Huismans H; Viljoen GJ
    Arch Virol; 1994; 135(3-4):405-18. PubMed ID: 7979976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major core protein VP7 of Australian bluetongue virus serotype 15: sequence and antigenicity divergence from other BTV serotypes.
    Wang LF; Kattenbelt JA; Gould AR; Pritchard LI; Crameri GS; Eaton BT
    J Gen Virol; 1994 Sep; 75 ( Pt 9)():2421-5. PubMed ID: 8077943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High level expression of the major core protein VP7 and the non-structural protein NS3 of bluetongue virus in yeast: use of expressed VP7 as a diagnostic, group-reactive antigen in a blocking ELISA.
    Martyn JC; Gould AR; Eaton BT
    Virus Res; 1991 Mar; 18(2-3):165-78. PubMed ID: 1645903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topography and immunogenicity of bluetongue virus VP7 epitopes.
    Wang LF; Hyatt AD; Whiteley PL; Andrew M; Li JK; Eaton BT
    Arch Virol; 1996; 141(1):111-23. PubMed ID: 8629938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and characterization of the major group-specific core antigen VP7 of bluetongue virus synthesized by a recombinant baculovirus.
    Oldfield S; Adachi A; Urakawa T; Hirasawa T; Roy P
    J Gen Virol; 1990 Nov; 71 ( Pt 11)():2649-56. PubMed ID: 2174958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baculovirus expression of non-structural protein NS2 and core protein VP7 of African horsesickness virus serotype 3 and their use as antigens in an indirect ELISA.
    Bremer CW; du Plessis DH; van Dijk AA
    J Virol Methods; 1994 Jul; 48(2-3):245-56. PubMed ID: 7989441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and antigenic characterization of the major core protein VP7 of Chuzan virus, a member of the Palyam serogroup orbiviruses.
    Yamakawa M; Furuuchi S
    Vet Microbiol; 2001 Dec; 83(4):333-41. PubMed ID: 11600267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serogrouping of United States and some African serotypes of bluetongue virus using RT-PCR.
    Aradaib IE; Mohamed ME; Abdalla TM; Sarr J; Abdalla MA; Yousof MA; Hassan YA; Karrar AR
    Vet Microbiol; 2005 Dec; 111(3-4):145-50. PubMed ID: 16280207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterologous prime boost vaccination with DNA and recombinant modified vaccinia virus Ankara protects IFNAR(-/-) mice against lethal bluetongue infection.
    Calvo-Pinilla E; Rodríguez-Calvo T; Sevilla N; Ortego J
    Vaccine; 2009 Dec; 28(2):437-45. PubMed ID: 19857449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of African horse sickness virus VP7 antigen, synthesised in bacteria, and anti-VP7 monoclonal antibodies in a competitive ELISA.
    Wade-Evans AM; Woolhouse T; O'Hara R; Hamblin C
    J Virol Methods; 1993 Dec; 45(2):179-88. PubMed ID: 8113344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prokaryotic expression of truncated VP7 of bluetongue virus (BTV) and reactivity of the purified recombinant protein with all BTV type-specific sera.
    Pathak KB; Biswas SK; Tembhurne PA; Hosamani M; Bhanuprakash V; Prasad G; Singh RK; Rasool TJ; Mondal B
    J Virol Methods; 2008 Sep; 152(1-2):6-12. PubMed ID: 18611412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a Double-Antigen Microsphere Immunoassay for Simultaneous Group and Serotype Detection of Bluetongue Virus Antibodies.
    Breard E; Garnier A; Despres P; Blaise Boisseau S; Comtet L; Viarouge C; Bakkali-Kassimi L; Pourquier P; Hudelet P; Vitour D; Rossi S; Belbis G; Sailleau C; Zientara S
    Transbound Emerg Dis; 2017 Dec; 64(6):1837-1847. PubMed ID: 27667484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of an IGM-specific ELISA for early detection of bluetongue virus infections in domestic ruminants sera.
    Bréard E; Gorlier A; Viarouge C; Donnet F; Sailleau C; Schulz C; Hoffmann B; Comtet L; Beer M; Zientara S; Vitour D
    Transbound Emerg Dis; 2019 Jan; 66(1):537-545. PubMed ID: 30394662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody responses and protective immunity to recombinant vaccinia virus-expressed bluetongue virus antigens.
    Lobato ZI; Coupar BE; Gray CP; Lunt R; Andrew ME
    Vet Immunol Immunopathol; 1997 Nov; 59(3-4):293-309. PubMed ID: 9477479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serogroup-reactive and type-specific detection of bluetongue virus antibodies using chicken scFvs in inhibition ELISAs.
    Fehrsen J; van Wyngaardt W; Mashau C; Potgieter AC; Chaudhary VK; Gupta A; Jordaan FA; du Plessis DH
    J Virol Methods; 2005 Oct; 129(1):31-9. PubMed ID: 15946749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the major core structural protein (VP7) of bluetongue virus, by a recombinant capripox virus, provides partial protection of sheep against a virulent heterotypic bluetongue virus challenge.
    Wade-Evans AM; Romero CH; Mellor P; Takamatsu H; Anderson J; Thevasagayam J; Fleming MJ; Mertens PP; Black DN
    Virology; 1996 Jun; 220(1):227-31. PubMed ID: 8659119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competitive ELISA for serodiagnosis of bluetongue: evaluation of group-specific monoclonal antibodies and expressed VP7 antigen.
    Afshar A; Eaton BT; Wright PF; Pearson JE; Anderson J; Jeggo M; Trotter HC
    J Vet Diagn Invest; 1992 Jul; 4(3):231-7. PubMed ID: 1325189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microspheres-prime/rMVA-boost vaccination enhances humoral and cellular immune response in IFNAR(-/-) mice conferring protection against serotypes 1 and 4 of bluetongue virus.
    Marín-López A; Calvo-Pinilla E; Barriales D; Lorenzo G; Benavente J; Brun A; Martínez-Costas JM; Ortego J
    Antiviral Res; 2017 Jun; 142():55-62. PubMed ID: 28322923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Validation of an ELISA for the Detection of Bluetongue Virus Serotype 4-Specific Antibodies.
    Bréard E; Turpaud M; Beaud G; Postic L; Fablet A; Beer M; Sailleau C; Caignard G; Viarouge C; Hoffmann B; Vitour D; Zientara S
    Viruses; 2021 Aug; 13(9):. PubMed ID: 34578322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcore- and core-like particles of Broadhaven virus (BRDV), a tick-borne orbivirus, synthesized from baculovirus expressed VP2 and VP7, the major core proteins of BRDV.
    Moss SR; Nuttall PA
    Virus Res; 1994 Jun; 32(3):401-7. PubMed ID: 8079519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.